logoLCFD
Clinical Guidelines
Search your location
    Enable Location Service
    • Home
    • Clinical Guidelines
    • Text Page
    • Others
    • Login
      • Login
      • Notifications 0
    • Search your location
        Enable Location Service
      Login0
      • Home
      • Clinical Guidelines
      • Text Page

      Others

      • Clinical Guidelines
      • Text Page
      1. Home
      2. Clinical Guidelines
      3. REVISION PAGE
      4. 2020 REVISIONS

      2020 REVISIONS

      2020 REVISIONS

      2020 REVISIONS

      ShareBookmarks
      REVISIONS TO 2018 CLINICAL GUIDELINES

      1. Changed name from “Protocols” to “Guidelines”
      2. ANAPHYLACTIC REACTION Added oral Dexamethasone. Clarified Epinephrine dosing.
      3. Do Not Resuscitate DNR. Completely rewritten
      4. RESPIRATORY DISTRESS (COPD/ASTHMA) Added oral Dexamethasone.
      5. SEIZURE (Adult) Added Midazolam 0.2 mg/kg to max of 10 mg. IM with comment.
      6. IMMINENT DELIVERY Added “consider TXA” for severe bleeding.
      7. TACHYCARDIA NARROW Reduced initial Adenosine dose to 6 mg. Changed dose of synchronized cardioversion to 50-100 joules.
      8. TACHYCARDIA WIDE Reduced initial Adenosine dose to 6 mg.
      9. SIEZURE (PED) Added Midazolam 0.2 mg./kg. to max of 10 IM.
      10. RESPIRATORY DISTRESS (PED) Added oral liquid Dexamethasone and clarified Epinephrine dosing.
      11. RESPIRATORY DISTRESS (CROUP) Added oral liquid Dexamethasone. Altered dosing of nebulized Epinephrine.

        • Terms of Use
        • Privacy Policy

        Powered By